222 related articles for article (PubMed ID: 30309390)
21. Inactivated and adjuvanted vaccine for the control of the African horse sickness virus serotype 9 infection: evaluation of efficacy in horses and guinea-pig model.
Lelli R; Molini U; Ronchi GF; Rossi E; Franchi P; Ulisse S; Armillotta G; Capista S; Khaiseb S; Di Ventura M; Pini A
Vet Ital; 2013; 49(1):89-98. PubMed ID: 23564590
[TBL] [Abstract][Full Text] [Related]
22. African Horse Sickness Caused by Genome Reassortment and Reversion to Virulence of Live, Attenuated Vaccine Viruses, South Africa, 2004-2014.
Weyer CT; Grewar JD; Burger P; Rossouw E; Lourens C; Joone C; le Grange M; Coetzee P; Venter E; Martin DP; MacLachlan NJ; Guthrie AJ
Emerg Infect Dis; 2016 Dec; 22(12):2087-2096. PubMed ID: 27442883
[TBL] [Abstract][Full Text] [Related]
23. African Horse Sickness Fever in Vaccinated Horses: Short Communication.
Wernery U; Joseph S; Raghavan R; Dyer B; Spendrup S
J Equine Vet Sci; 2020 May; 88():102967. PubMed ID: 32303305
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the pathogenicity of African Horsesickness (AHS) isolates in vaccinated animals.
von Teichman BF; Smit TK
Vaccine; 2008 Sep; 26(39):5014-21. PubMed ID: 18682269
[TBL] [Abstract][Full Text] [Related]
25. Humoral and cell-mediated immune responses to plant-produced African horse sickness virus VP7 quasi-crystals.
Fearon SH; Dennis SJ; Hitzeroth II; Rybicki EP; Meyers AE
Virus Res; 2021 Mar; 294():198284. PubMed ID: 33421520
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic DIVA tests accompanying the Disabled Infectious Single Animal (DISA) vaccine platform for African horse sickness.
van Rijn PA; Maris-Veldhuis MA; Boonstra J; van Gennip RGP
Vaccine; 2018 Jun; 36(25):3584-3592. PubMed ID: 29759377
[TBL] [Abstract][Full Text] [Related]
27. Immunogenicity of two adjuvant formulations of an inactivated African horse sickness vaccine in guinea-pigs and target animals.
Ronchi GF; Ulisse S; Rossi E; Franchi P; Armillotta G; Capista S; Peccio A; Di Ventura M; Pini A
Vet Ital; 2012; 48(1):55-76. PubMed ID: 22485003
[TBL] [Abstract][Full Text] [Related]
28. Assembly of Replication-Incompetent African Horse Sickness Virus Particles: Rational Design of Vaccines for All Serotypes.
Lulla V; Lulla A; Wernike K; Aebischer A; Beer M; Roy P
J Virol; 2016 Aug; 90(16):7405-7414. PubMed ID: 27279609
[TBL] [Abstract][Full Text] [Related]
29. Passive transfer and rate of decay of maternal antibody against African horse sickness virus in South African Thoroughbred foals.
Crafford JE; Lourens CW; Gardner IA; Maclachlan NJ; Guthrie AJ
Equine Vet J; 2013 Sep; 45(5):604-7. PubMed ID: 23294121
[TBL] [Abstract][Full Text] [Related]
30. Cross-protective immune responses against African horse sickness virus after vaccination with protein NS1 delivered by avian reovirus muNS microspheres and modified vaccinia virus Ankara.
Marín-López A; Barreiro-Piñeiro N; Utrilla-Trigo S; Barriales D; Benavente J; Nogales A; Martínez-Costas J; Ortego J; Calvo-Pinilla E
Vaccine; 2020 Jan; 38(4):882-889. PubMed ID: 31708178
[TBL] [Abstract][Full Text] [Related]
31. A single dose of African horse sickness virus (AHSV) VP2 based vaccines provides complete clinical protection in a mouse model.
Aksular M; Calvo-Pinilla E; Marín-López A; Ortego J; Chambers AC; King LA; Castillo-Olivares J
Vaccine; 2018 Nov; 36(46):7003-7010. PubMed ID: 30309744
[TBL] [Abstract][Full Text] [Related]
32. Oral susceptibility of South African Culicoides species to live-attenuated serotype-specific vaccine strains of African horse sickness virus (AHSV).
Paweska JT; Prinsloo S; Venter GJ
Med Vet Entomol; 2003 Dec; 17(4):436-47. PubMed ID: 14651659
[TBL] [Abstract][Full Text] [Related]
33. Control and eradication of African horse sickness with vaccine.
Sánchez-Vizcaíno JM
Dev Biol (Basel); 2004; 119():255-8. PubMed ID: 15742636
[TBL] [Abstract][Full Text] [Related]
34. Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge.
Alberca B; Bachanek-Bankowska K; Cabana M; Calvo-Pinilla E; Viaplana E; Frost L; Gubbins S; Urniza A; Mertens P; Castillo-Olivares J
Vaccine; 2014 Jun; 32(29):3670-4. PubMed ID: 24837765
[TBL] [Abstract][Full Text] [Related]
35. Antibodies in horses, mules and donkeys following monovalent vaccination against African horse sickness.
Hamblin C; Mellor PS; Graham SD; Hooghuis H; Montejano RC; Cubillo MA; Boned J
Epidemiol Infect; 1991 Apr; 106(2):365-71. PubMed ID: 1902185
[TBL] [Abstract][Full Text] [Related]
36. Future international management of African horse sickness vaccines.
House JA
Arch Virol Suppl; 1998; 14():297-304. PubMed ID: 9785514
[TBL] [Abstract][Full Text] [Related]
37. Recombinant baculovirus-synthesized African horsesickness virus (AHSV) outer-capsid protein VP2 provides protection against virulent AHSV challenge.
Roy P; Bishop DH; Howard S; Aitchison H; Erasmus B
J Gen Virol; 1996 Sep; 77 ( Pt 9)():2053-7. PubMed ID: 8811002
[TBL] [Abstract][Full Text] [Related]
38. Antiserum from mice vaccinated with modified vaccinia Ankara virus expressing African horse sickness virus (AHSV) VP2 provides protection when it is administered 48h before, or 48h after challenge.
Calvo-Pinilla E; de la Poza F; Gubbins S; Mertens PP; Ortego J; Castillo-Olivares J
Antiviral Res; 2015 Apr; 116():27-33. PubMed ID: 25643968
[TBL] [Abstract][Full Text] [Related]
39. Development of Differentiating Infected from Vaccinated Animals (DIVA) Real-Time PCR for African Horse Sickness Virus Serotype 1.
Wang Y; Ong J; Ng OW; Songkasupa T; Koh EY; Wong JPS; Puangjinda K; Fernandez CJ; Huangfu T; Ng LC; Chang SF; Yap HH
Emerg Infect Dis; 2022 Dec; 28(12):2446-2454. PubMed ID: 36417933
[TBL] [Abstract][Full Text] [Related]
40. Clinical, Virological and Immunological Responses after Experimental Infection with African Horse Sickness Virus Serotype 9 in Immunologically Naïve and Vaccinated Horses.
Durán-Ferrer M; Villalba R; Fernández-Pacheco P; Tena-Tomás C; Jiménez-Clavero MÁ; Bouzada JA; Ruano MJ; Fernández-Pinero J; Arias M; Castillo-Olivares J; Agüero M
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
